[{"Assets_0_Q2_USD":"100357000000.0","CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q2_USD":"0.54","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.67","EarningsPerShareBasic_2_Q2_USD":"1.26","EarningsPerShareDiluted_1_Q2_USD":"0.66","EarningsPerShareDiluted_2_Q2_USD":"1.25","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162000000000.0","MinorityInterest_0_Q2_USD":"61000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"6073000000.0","NetIncomeLoss_1_Q2_USD":"1421000000.0","NetIncomeLoss_2_Q2_USD":"2699000000.0","OfficialName":"Bristol-Myers Squibb Company Common Stock","PaymentsOfDividends_2_Q2_USD":"2335000000.0","ProfitLoss_1_Q2_USD":"1429000000.0","ProfitLoss_2_Q2_USD":"2712000000.0","RevenuesConverted_1_Q2_USD":"11887000000.0","RevenuesConverted_2_Q2_USD":"23535000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":"32661000000.0","StockholdersEquity_0_Q2_USD":"32600000000.0","Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"2149000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"2157000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"2133000000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"2140000000.0","filed":"20220727","footnote":null,"form":"10-Q","fp":"Q2","fy":"2022.0","name":"BRISTOL MYERS SQUIBB CO","period":"20220630","qtrs":"0","uom":"USD"}]